It has been recently reported that HE4 is also expressed in ductal carcinoma of the breast tissue (Geng et al., 2015); however, its serum expression levels and their diagnostic and prognostic potential in breast cancer remain to be elucidated. This evidence concerns the gene WFDC2 and breast carcinoma.